Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Steinberg

Showing results (441-450 of 481) with videos related to

Pageof 49
Sort By:
Journal of Hepatology|November 7, 2016
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinomaAustin G Duffy, Susanna V Ulahannan, Oxana Makorova-Rusher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trialAriel Lopez-Chavez, Anish Thomas, Arun Rajan, et al.
The Lancet. Haematology|December 4, 2018
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 studyKieron Dunleavy, Michelle A Fanale, Jeremy S Abramson, et al.
Hepatology (Baltimore, Md.)|December 23, 2018
Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract CancerChangqing Xie, Austin G Duffy, Donna Mabry-Hrones, et al.
British Journal of Haematology|April 21, 2015
Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative dataSusan E Bates, Robin Eisch, Alexander Ling, et al.
Bone Marrow Transplantation|August 10, 2018
Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patientsAna Zelic Kerep, Jacob Broome, Filip Pirsl, et al.
Nature|August 8, 2017
Identification of essential genes for cancer immunotherapyShashank J Patel, Neville E Sanjana, Rigel J Kishton, et al.
Blood|February 1, 2012
Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantationNancy M Hardy, Vicki Fellowes, Jeremy J Rose, et al.
Cancer Chemotherapy and Pharmacology|April 22, 2020
Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumorsGeraldine O 'Sullivan Coyne, Lihua Wang, Jennifer Zlott, et al.
The Journal of Allergy and Clinical Immunology|September 5, 2024
Hematopoietic cell transplantation for DOCK8 deficiency: Results from a prospective clinical trialAlexandra F Freeman, Corina E Gonzalez, Bonnie Yates, et al.
Pageof 49

Showing results (441-450 of 481) with videos related to

Sort By:
Pageof 49
Journal of Hepatology|November 7, 2016
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinomaAustin G Duffy, Susanna V Ulahannan, Oxana Makorova-Rusher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trialAriel Lopez-Chavez, Anish Thomas, Arun Rajan, et al.
The Lancet. Haematology|December 4, 2018
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 studyKieron Dunleavy, Michelle A Fanale, Jeremy S Abramson, et al.
Hepatology (Baltimore, Md.)|December 23, 2018
Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract CancerChangqing Xie, Austin G Duffy, Donna Mabry-Hrones, et al.
British Journal of Haematology|April 21, 2015
Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative dataSusan E Bates, Robin Eisch, Alexander Ling, et al.
Bone Marrow Transplantation|August 10, 2018
Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patientsAna Zelic Kerep, Jacob Broome, Filip Pirsl, et al.
Nature|August 8, 2017
Identification of essential genes for cancer immunotherapyShashank J Patel, Neville E Sanjana, Rigel J Kishton, et al.
Blood|February 1, 2012
Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantationNancy M Hardy, Vicki Fellowes, Jeremy J Rose, et al.
Cancer Chemotherapy and Pharmacology|April 22, 2020
Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumorsGeraldine O 'Sullivan Coyne, Lihua Wang, Jennifer Zlott, et al.
The Journal of Allergy and Clinical Immunology|September 5, 2024
Hematopoietic cell transplantation for DOCK8 deficiency: Results from a prospective clinical trialAlexandra F Freeman, Corina E Gonzalez, Bonnie Yates, et al.
Pageof 49